- Home
- Publications
- Publication Search
- Publication Details
Title
Novel avenues for Clostridium difficile infection drug discovery
Authors
Keywords
-
Journal
Expert Opinion on Drug Discovery
Volume 8, Issue 4, Pages 459-477
Publisher
Informa Healthcare
Online
2013-02-22
DOI
10.1517/17460441.2013.770466
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial
- (2014) D.D. Rhoads et al. Journal of Wound Care
- Characterization of bacteriophages virulent for Clostridium perfringens and identification of phage lytic enzymes as alternatives to antibiotics for potential control of the bacterium1
- (2013) B. S. Seal POULTRY SCIENCE
- Identification of Ligand Analogues that Control c-di-GMP Riboswitches
- (2012) Kazuhiro Furukawa et al. ACS Chemical Biology
- In VitroandIn VivoCharacterization of CB-183,315, a Novel Lipopeptide Antibiotic for Treatment of Clostridium difficile
- (2012) Carmela T. M. Mascio et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- MBX-500, a Hybrid Antibiotic withIn VitroandIn VivoEfficacy against Toxigenic Clostridium difficile
- (2012) Michelle M. Butler et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of an Oral Suspension of VP20621, Spores of Nontoxigenic Clostridium difficile Strain M3, in Healthy Subjects
- (2012) Stephen A. Villano et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Shiga Toxin-Producing Escherichia coli O104:H4: a New Challenge for Microbiology
- (2012) Maite Muniesa et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- Fecal Transplant via Retention Enema for Refractory or Recurrent Clostridium difficile Infection
- (2012) Zain Kassam ARCHIVES OF INTERNAL MEDICINE
- Optimizing the European Regulatory Framework for Sustainable Bacteriophage Therapy in Human Medicine
- (2012) Gilbert Verbeken et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- A Gastroenterologist's Guide to Probiotics
- (2012) Matthew A. Ciorba Clinical Gastroenterology and Hepatology
- Current State of Clostridium difficile Treatment Options
- (2012) A. A. Venugopal et al. CLINICAL INFECTIOUS DISEASES
- Oritavancin: Mechanism of Action
- (2012) George G. Zhanel et al. CLINICAL INFECTIOUS DISEASES
- Current Status of Clostridium difficile Infection Epidemiology
- (2012) F. C. Lessa et al. CLINICAL INFECTIOUS DISEASES
- Fidaxomicin: The Newest Addition to the Armamentarium Against Clostridium difficile Infections
- (2012) Jason W. Lancaster et al. CLINICAL THERAPEUTICS
- New horizons for host defense peptides and lantibiotics
- (2012) Michael John Dawson et al. CURRENT OPINION IN PHARMACOLOGY
- Biofilm-growing intestinal anaerobic bacteria
- (2012) Gianfranco Donelli et al. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
- Modulation of Toxin Production by the Flagellar Regulon in Clostridium difficile
- (2012) Annie Aubry et al. INFECTION AND IMMUNITY
- Probiotics for infectious diseases: more drugs, less dietary supplementation
- (2012) Katerina Kotzampassi et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Is primary prevention of Clostridium difficile infection possible with specific probiotics?
- (2012) Stuart Johnson et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Effectiveness of a short (4 day) course of oritavancin in the treatment of simulated Clostridium difficile infection using a human gut model
- (2012) C. H. Chilton et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Evaluation of NVB302 versus vancomycin activity in an in vitro human gut model of Clostridium difficile infection
- (2012) G. S. Crowther et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Natural antimicrobial peptides from bacteria: characteristics and potential applications to fight against antibiotic resistance
- (2012) M. Hassan et al. JOURNAL OF APPLIED MICROBIOLOGY
- Cyclic Diguanylate Inversely Regulates Motility and Aggregation in Clostridium difficile
- (2012) E. B. Purcell et al. JOURNAL OF BACTERIOLOGY
- Multiple Factors Modulate Biofilm Formation by the Anaerobic Pathogen Clostridium difficile
- (2012) T. Thapa et al. JOURNAL OF BACTERIOLOGY
- Experimental treatment of Staphylococcus aureus bovine intramammary infection using a guanine riboswitch ligand analog
- (2012) C. Ster et al. JOURNAL OF DAIRY SCIENCE
- Clinical and economic burden of Clostridium difficile infection in Europe: a systematic review of healthcare-facility-acquired infection
- (2012) P.N. Wiegand et al. JOURNAL OF HOSPITAL INFECTION
- Clostridium difficile Toxins: Mediators of Inflammation
- (2012) Aimee Shen Journal of Innate Immunity
- Discovery of LFF571: An Investigational Agent for Clostridium difficile Infection
- (2012) Matthew J. LaMarche et al. JOURNAL OF MEDICINAL CHEMISTRY
- Fecal transplant against relapsingClostridium difficile-associated diarrhea in 32 patients
- (2012) Christina Jorup-Rönström et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Phase I dose finding studies of an adjuvanted Clostridium difficile toxoid vaccine
- (2012) Richard N. Greenberg et al. VACCINE
- Alternatives to conventional antimicrobial drugs: a review of future prospects
- (2012) David H. Lloyd VETERINARY DERMATOLOGY
- What is needed for phage therapy to become a reality in Western medicine?
- (2012) Harald Brüssow VIROLOGY
- Pseudomonas Biofilms, Cystic Fibrosis, and Phage: a Silver Lining?
- (2012) H. Brussow mBio
- Bacteriophages MR299-2 and NH-4 Can Eliminate Pseudomonas aeruginosa in the Murine Lung and on Cystic Fibrosis Lung Airway Cells
- (2012) D. Alemayehu et al. mBio
- Targeted Restoration of the Intestinal Microbiota with a Simple, Defined Bacteriotherapy Resolves Relapsing Clostridium difficile Disease in Mice
- (2012) Trevor D. Lawley et al. PLoS Pathogens
- Phage Therapy: Concept to Cure
- (2012) Eric C. Keen Frontiers in Microbiology
- Riboswitches: Discovery of Drugs That Target Bacterial Gene-Regulatory RNAs
- (2011) Katherine E. Deigan et al. ACCOUNTS OF CHEMICAL RESEARCH
- Recent Advances in Developing Small Molecules Targeting RNA
- (2011) Lirui Guan et al. ACS Chemical Biology
- The Insect Peptide Coprisin Prevents Clostridium difficile-Mediated Acute Inflammation and Mucosal Damage through Selective Antimicrobial Activity
- (2011) Jin Ku Kang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivities of CB-183,315, Vancomycin, and Metronidazole against 556 Strains of Clostridium difficile, 445 Other Intestinal Anaerobes, and 56 Enterobacteriaceae Species
- (2011) Diane M. Citron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The antibiotic R&D pipeline: an update
- (2011) Daniela Jabes CURRENT OPINION IN MICROBIOLOGY
- Emerging therapies forClostridium difficileinfections
- (2011) Lynne V McFarland EXPERT OPINION ON EMERGING DRUGS
- Time to considerClostridiumprobiotics?
- (2011) Stephen T Cartman Future Microbiology
- Structure-Based Modification of a Clostridium difficile-Targeting Endolysin Affects Activity and Host Range
- (2011) M. J. Mayer et al. JOURNAL OF BACTERIOLOGY
- Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
- (2011) Lawrence J. Brandt et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Tackling antibiotic resistance
- (2011) Karen Bush et al. NATURE REVIEWS MICROBIOLOGY
- Genome Mining for Radical SAM Protein Determinants Reveals Multiple Sactibiotic-Like Gene Clusters
- (2011) Kiera Murphy et al. PLoS One
- Mechanism for gene control by a natural allosteric group I ribozyme
- (2011) A. G. Y. Chen et al. RNA
- The role of toxin A and toxin B in the virulence of Clostridium difficile
- (2011) Glen P. Carter et al. TRENDS IN MICROBIOLOGY
- c-di-GMP Turn-Over in Clostridium difficile Is Controlled by a Plethora of Diguanylate Cyclases and Phosphodiesterases
- (2011) Eric Bordeleau et al. PLoS Genetics
- The Clostridium difficile Cell Wall Protein CwpV is Antigenically Variable between Strains, but Exhibits Conserved Aggregation-Promoting Function
- (2011) Catherine B. Reynolds et al. PLoS Pathogens
- Dose–Response Efficacy of a Proprietary Probiotic Formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for Antibiotic-Associated Diarrhea and Clostridium difficile-Associated Diarrhea Prophylaxis in Adult Patients
- (2010) Xing Wang Gao et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Bacteriophage treatment significantly reduces viable Clostridium difficile and prevents toxin production in an in vitro model system
- (2010) Emma Meader et al. ANAEROBE
- Clostridium difficile: progress and challenges
- (2010) John G. Bartlett Annals of the New York Academy of Sciences
- Rational Design of Inhibitors and Activity-Based Probes Targeting Clostridium difficile Virulence Factor TcdB
- (2010) Aaron W. Puri et al. CHEMISTRY & BIOLOGY
- Management ofClostridium difficileInfection: Thinking Inside and Outside the Box
- (2010) Dale N. Gerding et al. CLINICAL INFECTIOUS DISEASES
- New antibiotics for selective treatment of gastrointestinal infection caused byClostridium difficile
- (2010) Alan P Johnson EXPERT OPINION ON THERAPEUTIC PATENTS
- Identification of a Genetic Locus Responsible for Antimicrobial Peptide Resistance inClostridium difficile
- (2010) Shonna M. McBride et al. INFECTION AND IMMUNITY
- Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)
- (2010) Stuart H. Cohen et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- The emergence of ‘hypervirulence’ in Clostridium difficile
- (2010) Stephen T. Cartman et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- Bacteriophage endolysins: A novel anti-infective to control Gram-positive pathogens
- (2010) Vincent A. Fischetti INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- Fundamental functionality: recent developments in understanding the structure–activity relationships of lantibiotic peptides
- (2010) Avena C Ross et al. JOURNAL OF ANTIBIOTICS
- Fecal Flora Reconstitution for Recurrent Clostridium difficile Infection: Results and Methodology
- (2010) Faith Rohlke et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Evaluation of a Chromogenic Culture Medium for Isolation of Clostridium difficile within 24 Hours
- (2010) J. D. Perry et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Bacteriophages Can Treat and PreventPseudomonas aeruginosaLung Infections
- (2010) Laurent Debarbieux et al. JOURNAL OF INFECTIOUS DISEASES
- Treatment with Monoclonal Antibodies againstClostridium difficileToxins
- (2010) Israel Lowy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile
- (2010) M. C. Rea et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effect of broad- and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon
- (2010) M. C. Rea et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An Allosteric Self-Splicing Ribozyme Triggered by a Bacterial Second Messenger
- (2010) E. R. Lee et al. SCIENCE
- Topical treatment of Pseudomonas aeruginosa otitis of dogs with a bacteriophage mixture: A before/after clinical trial
- (2010) Catherine Hawkins et al. VETERINARY MICROBIOLOGY
- Systematic review and meta-analysis ofSaccharomyces boulardiiin adult patients
- (2010) Lynne V McFarland WORLD JOURNAL OF GASTROENTEROLOGY
- Antimicrobial peptides: The ancient arm of the human immune system
- (2010) Jochen Wiesner et al. Virulence
- The fascination with probiotics for Clostridium difficile infection: Lack of evidence for prophylactic or therapeutic efficacy
- (2009) Mark Miller ANAEROBE
- Clostridium difficile infection: Historic review
- (2009) John G. Bartlett ANAEROBE
- Tolevamer Is Not Efficacious in the Neutralization of Cytotoxin in a Human Gut Model of Clostridium difficile Infection
- (2009) S. D. Baines et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Anti-Clostridium difficile Potential of Tetramic Acid Derivatives from Pseudomonas aeruginosa Quorum-Sensing Autoinducers
- (2009) C. Ueda et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistantPseudomonas aeruginosa; a preliminary report of efficacy
- (2009) A. Wright et al. CLINICAL OTOLARYNGOLOGY
- Anionic Antimicrobial Peptides from Eukaryotic Organisms
- (2009) Frederick Harris et al. CURRENT PROTEIN & PEPTIDE SCIENCE
- Antimicrobial resistance in Clostridium difficile
- (2009) Haihui Huang et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- New approach to the management of Clostridium difficile infection: colonisation with non-toxigenic C. difficile during daily ampicillin or ceftriaxone administration
- (2009) Michelle M. Merrigan et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- New trends in Clostridium difficile virulence and pathogenesis
- (2009) C. Denève et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Spectrum of activity and mode of action of REP3123, a new antibiotic to treat Clostridium difficile infections
- (2009) I. A. Critchley et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Comparative in vitro activity of REP3123 against Clostridium difficile and other anaerobic intestinal bacteria
- (2009) D. M. Citron et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Inhibitory effect of REP3123 on toxin and spore formation in Clostridium difficile, and in vivo efficacy in a hamster gastrointestinal infection model
- (2009) U. A. Ochsner et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Quality-Controlled Small-Scale Production of a Well-Defined Bacteriophage Cocktail for Use in Human Clinical Trials
- (2009) Maya Merabishvili et al. PLoS One
- The Safety of Probiotics
- (2008) David R. Snydman CLINICAL INFECTIOUS DISEASES
- Emergence ofClostridium difficileInfection Due to a New Hypervirulent Strain, Polymerase Chain Reaction Ribotype 078
- (2008) Abraham Goorhuis et al. CLINICAL INFECTIOUS DISEASES
- De novo designed synthetic mimics of antimicrobial peptides
- (2008) Richard W Scott et al. CURRENT OPINION IN BIOTECHNOLOGY
- Bacteriophage lysins as effective antibacterials
- (2008) Vincent A Fischetti CURRENT OPINION IN MICROBIOLOGY
- Therapeutic frontiers: preventing and treating infectious diseases by inhibiting bacterial quorum sensing
- (2008) C. A. Martin et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Human α-Defensins Inhibit Clostridium difficile Toxin B
- (2008) Torsten Giesemann et al. GASTROENTEROLOGY
- Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study)
- (2008) Enno Jacobs et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Pharmacodynamic activity of the lantibiotic MU1140
- (2008) Oliver G. Ghobrial et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Molecular Characterization of a Clostridium difficile Bacteriophage and Its Cloned Biologically Active Endolysin
- (2008) M. J. Mayer et al. JOURNAL OF BACTERIOLOGY
- Phage therapy experience at the Eliava Institute
- (2008) M. Kutateladze et al. MEDECINE ET MALADIES INFECTIEUSES
- Clostridium difficile— More Difficult Than Ever
- (2008) Ciarán P. Kelly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Riboswitches in Eubacteria Sense the Second Messenger Cyclic Di-GMP
- (2008) N. Sudarsan et al. SCIENCE
- Toxicity of HIV protease inhibitors: clinical considerations
- (2008) Christoph Boesecke et al. Current Opinion in HIV and AIDS
- New antimicrobial agents for patients with Clostridium difficile infections
- (2008) John G. Bartlett Current Infectious Disease Reports
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now